GJ
Gary S Jacob
Chief Development OfficerDirector

Gary S Jacob insider trades: OKYO Pharma (OKYO) stock purchases

Chief Development Officer, OKYO Pharma Last trade Jul 21, 2026 59 Form 4 filings
$0
Sold, last 12 months
0 sales
$5K
Bought, last 12 months
1 buy
10
Open-market trades
since 2005
11
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Gary reports to the SEC

and 5 more companies

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 21, 2026OKYO↑ Buy$5K
May 19, 2022OKYO↑ Buy$50K
Mar 23, 2021CRDF↑ Buy$25K
Feb 17, 2021VRPX↑ Buy$24K
Dec 1, 2020HEPA↑ Buy$20K
May 14, 2020CRDF↑ Buy$25K
May 26, 2017SGYP↑ Buy$20K
May 27, 2014SGYP↑ Buy$17K
Aug 21, 2006KAL↑ Buy$4K
Jun 16, 2005KAL↑ Buy$5K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other OKYO insiders

Open-market trades in the last 12 months

About Gary S Jacob's insider trades

Gary S Jacob is Chief Development Officer at OKYO Pharma (OKYO). Since Jun 16, 2005, Gary has reported 10 open-market purchases worth $194K and no sales on SEC Form 4. In the last 12 months: 1 buy ($5K).

Their filings also include grants and awards (39 filings), other transactions (5 filings), option exercises (4 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OKYO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.